Related Experiment Video
Updated: Jun 28, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Does coronary artery calcification in patients with diabetic nephropathy depend on the advancement of renal failure?
Marcin Krzanowski1, Beata Kuśnierz-Cabala, Przemysław Miarka
1Department of Nephrology, Jagiellonian University, Collegium Medicum, Cracow, Poland. mkrzanowski@op.pl
Insights
Vascular calcification in diabetic kidney disease patients on peritoneal dialysis was similar to those with earlier stages of chronic kidney disease. Despite worse calcium-phosphate balance and inflammation, peritoneal dialysis did not significantly increase coronary artery calcification scores.
Area of Science:
- Nephrology
- Cardiology
- Diabetology
Background:
- Vascular calcification and calcium-phosphate disorders are common in diabetic nephropathy.
- Peritoneal dialysis (PD) is a treatment for end-stage renal disease (ESRD).
Purpose of the Study:
- To compare vascular calcification prevalence and advancement in diabetic nephropathy patients on PD versus those with chronic kidney disease (CKD) stages 2-4.
- To investigate the relationship between calcium-phosphate balance, inflammation, and vascular calcification in these groups.
Main Methods:
- Retrospective study of 31 type 2 diabetes patients with nephropathy.
- Group 1: 12 patients on PD (ESRD).
- Group 2: 19 patients with CKD stages 2-4.
- Coronary artery calcification score (CaSc) assessed via multi-slice computed tomography (MSCT).
- Biochemical markers including parathyroid hormone, fibrinogen, and alkaline phosphatase were measured.
Main Results:
- No significant difference in CaSc between PD and CKD groups (1085.2 vs. 452.4 AgU).
- PD patients exhibited significantly higher parathyroid hormone (658.2 vs. 74.3 pg/ml), fibrinogen (5.82 vs. 3.89 g/l), and alkaline phosphatase (330.9 vs. 168.0 U/l) levels.
- PD group showed more pronounced calcium-phosphate abnormalities and inflammation markers.
Conclusions:
- Despite poorer biochemical profiles, PD patients did not show significantly higher coronary artery calcification compared to CKD stages 2-4 patients.
- Further research is needed to understand the long-term impact of PD on vascular calcification in diabetic nephropathy.
Abstract:
Calcium-phosphate disorders and vascular calcification are highly prevalent in patients with diabetes mellitus and nephropathy. The aim of the study was to compare the prevalence and advancement of vascular calcification in patients with end-stage diabetic nephropathy on peritoneal dialysis and diabetic patients with chronic renal disease stages 2-4. The study group included 31 patients with type 2 diabetes and diabetic nephropathy divided into 2 groups: 12 patients (aged 50-74 years: mean 58.6+/-8.8) undergoing peritoneal dialysis and 19 patients (aged 46-82 years; mean 65.8+/-9.7) with chronic kidney disease stages 2-4 (GFR range 24-78 ml/min/1.73 m2). Coronary artery calcification score, was assessed using multi-slice computed tomography. Coronary artery calcification score did not differ significantly between groups (CaSc values 1085.2 vs 452.4 AgU; NS). The patients undergoing peritoneal dialysis showed significantly higher levels of parathyroid hormone (658.2 vs. 74.3 pg/ml; p=0.001), fibrinogen (5.82 vs. 3.89 g/l; p<0.0001) and alkaline phosphatase (330.9 vs. 168.0 U/l; p=0.001). Despite more advanced abnormalities in calcium-phosphate balance parameters and more active inflammation in peritoneal dialysis subjects we failed to demonstrate any statistically significant difference in coronary artery calcification score between patients with diabetic nephropathy on peritoneal dialysis and those with chronic kidney disease stages 2-4.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease I: Introduction
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

